We came up with a drug cocktail consisting of tocilizumab, which is currently used to treat rheumatoid arthritis, and reparixin, which is currently in clinical trials against breast cancer.
Desarrollamos un cóctel de drogas conformado por tocilizumab, que se usa actualmente para tratar la artritis reumatoidea, y reparixina, que se usa en ensayos clínicos contra el cáncer de mama.